Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
 
 
 
  Blog Calendar  
 
SuMoTuWeThFrSa
   1234
567891011
12131415161718
19202122232425
262728293031 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Raymond Anton, Medical University of South Carolina, Charleston, SC

Catasys Health - Saturday, August 01, 2009

Randomized, Stratified, Double-Blind, Placebo-Controlled Trial of Flumazenil and Gabapentin for the Treatment of Alcohol Dependence
Published in the Journal of Clinical Psychopharmacology, August 2009; 29(4):334-342.

 The OnTrak Medical Treatment Program achieved a significant reduction in use and cravings among members with symptoms of alcohol withdrawal (>6 CIWA) when compared to placebo.

Among members with more symptoms of alcohol withdrawal, the Prometa group experienced: ยป More
| 1 |

 
 
  Tags
 
withdrawal urine drug screen substance dependence costs chronic pain high-utilizing naloxone predictive modeling stimulants dependence issues depression health plan ADD primary care Health Care Utilization randomized pain pills opioid marijuana drinking CIWA narcotic stratified buprenorphine cocaine treatment cigarettes drug addicts Raymond Anton contract overdose care coaching reduction in craving oxycodone morphine trauma post-traumatic stress disorder recovery diabetes addiction health reform substance dependence health insurance binge drinking drug overdose gabapentin medical facebook UnitedHealthcare behavioral health fentanyl methadone methamphetamine double-blind drug use SD health insurance alcohol health insurance Catasys sober reducing craving behavioral health care services medical costs OxyContin behavioral health care over-the-counter substances substance use disorder psychosocial codeine addict ER cocaine PTSD Opioid Treatment ADHD nicotine placebo hospitalizations opiates anxiety percocet opioid abuse prometa reduction in use vivitrol drug treatment sugar identification pain killers mental illness smoking drug addiction addiction treatment Harold Urschel opiod-based flumazenil heroin craving medical and behavioral costs behavioral healthcare services meth recovery network relapse prevention mental health depression screening Journal of Psychopharmacology alcohol dependence placebo-controlled Opioid Medications hospital hydrocodone Research Across America Opioid Prescribing relapse prescriptions alcohol drinking Co Occurring Disorders social network SD members bipolar disorder opioid antagonist emergency room stress suboxone methamphetamine dependence physician- patient relations communication craving score opioid overdose drug abuse pain medication data mining opioid-drug interactions vicodin treatment OnTrak behavioral healthcare alcoholism substance dependence alcohol treatment sobriety muscle relaxant painkillers opiod abuse
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy/Photo Disclaimer
 
  Copyright © 2013 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025 | Toll Free: 1-866-517-1414